{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T06:17:55Z","timestamp":1768889875267,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T00:00:00Z","timestamp":1507161600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471054"],"award-info":[{"award-number":["81471054"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s12026-017-8956-5","type":"journal-article","created":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T15:28:18Z","timestamp":1507217298000},"page":"179-186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Human amylin induces CD4+Foxp3+ regulatory T cells in the protection from autoimmune diabetes"],"prefix":"10.1007","volume":"66","author":[{"given":"Xiao-xi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-chao","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin-yuan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,5]]},"reference":[{"key":"8956_CR1","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","volume":"84","author":"GJ Cooper","year":"1987","unstructured":"Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A. 1987;84:8628\u201332.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8956_CR2","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","volume":"84","author":"P Westermark","year":"1987","unstructured":"Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci U S A. 1987;84:3881\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8956_CR3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.regpep.2006.06.004","volume":"137","author":"BR Gedulin","year":"2006","unstructured":"Gedulin BR, Jodka CM, Herrmann K, Young AA. Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187. Regul Pept. 2006;137:121\u20137.","journal-title":"Regul Pept"},{"key":"8956_CR4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/15209150260007390","volume":"4","author":"SV Edelman","year":"2002","unstructured":"Edelman SV, Weyer C. Unresolved challenges with insulin therapy in type 1 and type 2 diabetes: potential benefit of replacing amylin, a second beta-cell hormone. Diabetes Technol Ther. 2002;4:175\u201389.","journal-title":"Diabetes Technol Ther"},{"key":"8956_CR5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-nutr-071812-161201","volume":"34","author":"MR Hayes","year":"2014","unstructured":"Hayes MR, Mietlicki-Baase EG, Kanoski SE, De Jonghe BC. Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose. Annu Rev Nutr. 2014;34:237\u201360.","journal-title":"Annu Rev Nutr"},{"key":"8956_CR6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00452067","volume":"29","author":"CF Howard Jr","year":"1986","unstructured":"Howard CF Jr. Longitudinal studies on the development of diabetes in individual Macaca nigra. Diabetologia. 1986;29:301\u20136.","journal-title":"Diabetologia"},{"key":"8956_CR7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0046-8177(81)80197-9","volume":"12","author":"AL Maloy","year":"1981","unstructured":"Maloy AL, Longnecker DS, Greenberg ER. The relation of islet amyloid to the clinical type of diabetes. Hum Pathol. 1981;12:917\u201322.","journal-title":"Hum Pathol"},{"key":"8956_CR8","doi-asserted-by":"crossref","first-page":"11338","DOI":"10.1021\/bi020314u","volume":"41","author":"M Anguiano","year":"2002","unstructured":"Anguiano M, Nowak RJ, Lansbury PT Jr. Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes. Biochemistry. 2002;41:11338\u201343.","journal-title":"Biochemistry"},{"key":"8956_CR9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.trsl.2008.10.009","volume":"153","author":"HL Zhao","year":"2009","unstructured":"Zhao HL, Sui Y, Guan J, He L, Gu XM, Wong HK, et al. Amyloid oligomers in diabetic and nondiabetic human pancreas. Translational research : the journal of laboratory and clinical medicine. 2009;153:24\u201332.","journal-title":"Translational research : the journal of laboratory and clinical medicine"},{"key":"8956_CR10","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1097\/MPA.0b013e3181788e18","volume":"37","author":"HL Zhao","year":"2008","unstructured":"Zhao HL, Sui Y, Guan J, He L, Lai FM, Zhong DR, et al. Higher islet amyloid load in men than in women with type 2 diabetes mellitus. Pancreas. 2008;37:e68\u201373.","journal-title":"Pancreas"},{"key":"8956_CR11","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/MPA.0b013e3182965e6e","volume":"42","author":"J Guan","year":"2013","unstructured":"Guan J, Zhao HL, Sui Y, He L, Lee HM, Lai FM, et al. Histopathological correlations of islet amyloidosis with apolipoprotein E polymorphisms in type 2 diabetic Chinese patients. Pancreas. 2013;42:1129\u201337.","journal-title":"Pancreas"},{"key":"8956_CR12","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2337\/diabetes.52.11.2759","volume":"52","author":"HL Zhao","year":"2003","unstructured":"Zhao HL, Lai FM, Tong PC, Zhong DR, Yang D, Tomlinson B, et al. Prevalence and clinicopathological characteristics of islet amyloid in Chinese patients with type 2 diabetes. Diabetes. 2003;52:2759\u201366.","journal-title":"Diabetes"},{"key":"8956_CR13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.biocel.2010.12.008","volume":"43","author":"XL Li","year":"2011","unstructured":"Li XL, Chen T, Wong YS, Xu G, Fan RR, Zhao HL, et al. Involvement of mitochondrial dysfunction in human islet amyloid polypeptide-induced apoptosis in INS-1E pancreatic beta cells: an effect attenuated by phycocyanin. Int J Biochem Cell Biol. 2011;43:525\u201334.","journal-title":"Int J Biochem Cell Biol"},{"key":"8956_CR14","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.biocel.2009.01.002","volume":"41","author":"XL Li","year":"2009","unstructured":"Li XL, Xu G, Chen T, Wong YS, Zhao HL, Fan RR, et al. Phycocyanin protects INS-1E pancreatic beta cells against human islet amyloid polypeptide-induced apoptosis through attenuating oxidative stress and modulating JNK and p38 mitogen-activated protein kinase pathways. Int J Biochem Cell Biol. 2009;41:1526\u201335.","journal-title":"Int J Biochem Cell Biol"},{"key":"8956_CR15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/MPA.0b013e3181d12613","volume":"39","author":"H Zhao","year":"2010","unstructured":"Zhao H, Guan J, Lee HM, Sui Y, He L, Siu JJ, et al. Up-regulated pancreatic tissue microRNA-375 associates with human type 2 diabetes through beta-cell deficit and islet amyloid deposition. Pancreas. 2010;39:843\u20136.","journal-title":"Pancreas"},{"key":"8956_CR16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/MPA.0b013e31817fe025","volume":"38","author":"HL Zhao","year":"2009","unstructured":"Zhao HL, Guan J, Sui Y, He L, Lai FF. Islet amyloidosis and beta-cell neogenesis in chronic calcifying pancreatitis with non-insulin-dependent diabetes mellitus. Pancreas. 2009;38:342\u20134.","journal-title":"Pancreas"},{"key":"8956_CR17","unstructured":"Zhao H, Zhang J, Mu X. Patent: applications of a human polypeptide in immune inhibitor production. China, 2013."},{"key":"8956_CR18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0092-8674(00)81106-X","volume":"85","author":"R Tisch","year":"1996","unstructured":"Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell. 1996;85:291\u20137.","journal-title":"Cell"},{"key":"8956_CR19","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.2337\/dc07-2446","volume":"31","author":"HJ Woerle","year":"2008","unstructured":"Woerle HJ, Albrecht M, Linke R, Zschau S, Neumann C, Nicolaus M, et al. Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide. Diabetes Care. 2008;31:2325\u201331.","journal-title":"Diabetes Care"},{"key":"8956_CR20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0167-0115(96)00025-0","volume":"63","author":"E Karlsson","year":"1996","unstructured":"Karlsson E, Stridsberg M, Sandler S. Islet amyloid polypeptide (IAPP) secretion from pancreatic islets isolated from non-obese diabetic (NOD) mice. Regul Pept. 1996;63:39\u201345.","journal-title":"Regul Pept"},{"key":"8956_CR21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1463-1326.2010.01337.x","volume":"13","author":"D Singh-Franco","year":"2011","unstructured":"Singh-Franco D, Perez A, Harrington C. The effect of pramlintide acetate on glycemic control and weight in patients with type 2 diabetes mellitus and in obese patients without diabetes: a systematic review and meta-analysis. Diabetes Obes Metab. 2011;13:169\u201380.","journal-title":"Diabetes Obes Metab"},{"key":"8956_CR22","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.2337\/dc12-0330","volume":"35","author":"SA Weinzimer","year":"2012","unstructured":"Weinzimer SA, Sherr JL, Cengiz E, Kim G, Ruiz JL, Carria L, et al. Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes. Diabetes Care. 2012;35:1994\u20139.","journal-title":"Diabetes Care"},{"key":"8956_CR23","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.4049\/jimmunol.175.3.1991","volume":"175","author":"AP Olcott","year":"2005","unstructured":"Olcott AP, Tian J, Walker V, Dang H, Middleton B, Adorini L, et al. Antigen-based therapies using ignored determinants of beta cell antigens can more effectively inhibit late-stage autoimmune disease in diabetes-prone mice. J Immunol. 2005;175:1991\u20139.","journal-title":"J Immunol"},{"key":"8956_CR24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-62703-523-1_2","volume":"1040","author":"C Westwell-Roper","year":"2013","unstructured":"Westwell-Roper C, Dunne A, Kim ML, Verchere CB, Masters SL. Activating the NLRP3 inflammasome using the amyloidogenic peptide IAPP. Methods Mol Biol. 2013;1040:9\u201318.","journal-title":"Methods Mol Biol"},{"key":"8956_CR25","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.4049\/jimmunol.1301480","volume":"191","author":"RL Baker","year":"2013","unstructured":"Baker RL, Delong T, Barbour G, Bradley B, Nakayama M, Haskins K. Cutting edge: CD4 T cells reactive to an islet amyloid polypeptide peptide accumulate in the pancreas and contribute to disease pathogenesis in nonobese diabetic mice. J Immunol. 2013;191:3990\u20134.","journal-title":"J Immunol"},{"key":"8956_CR26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.aad2791","volume":"351","author":"T Delong","year":"2016","unstructured":"Delong T, Wiles TA, Baker RL, Bradley B, Barbour G, Reisdorph R, et al. Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion. Science. 2016;351:711\u20134.","journal-title":"Science"},{"key":"8956_CR27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jaut.2016.10.007","volume":"78","author":"TA Wiles","year":"2017","unstructured":"Wiles TA, Delong T, Baker RL, Bradley B, Barbour G, Powell RL, et al. An insulin-IAPP hybrid peptide is an endogenous antigen for CD4 T cells in the non-obese diabetic mouse. J Autoimmun. 2017;78:11\u20138.","journal-title":"J Autoimmun"},{"key":"8956_CR28","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1146\/annurev.immunol.23.021704.115643","volume":"23","author":"MS Anderson","year":"2005","unstructured":"Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol. 2005;23:447\u201385.","journal-title":"Annu Rev Immunol"},{"key":"8956_CR29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","volume":"52","author":"AE Butler","year":"2003","unstructured":"Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102\u201310.","journal-title":"Diabetes"},{"key":"8956_CR30","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/diabetes.53.6.1509","volume":"53","author":"AE Butler","year":"2004","unstructured":"Butler AE, Jang J, Gurlo T, Carty MD, Soeller WC, Butler PC. Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes. Diabetes. 2004;53:1509\u201316.","journal-title":"Diabetes"},{"key":"8956_CR31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0168-8227(92)90073-Z","volume":"15","author":"T Hanabusa","year":"1992","unstructured":"Hanabusa T, Kubo K, Oki C, Nakano Y, Okai K, Sanke T, et al. Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 1992;15:89\u201396.","journal-title":"Diabetes Res Clin Pract"},{"key":"8956_CR32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/BF00404025","volume":"34","author":"E Hartter","year":"1991","unstructured":"Hartter E, Svoboda T, Ludvik B, Schuller M, Lell B, Kuenburg E, et al. Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans. Diabetologia. 1991;34:52\u20134.","journal-title":"Diabetologia"},{"key":"8956_CR33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0896-8411(95)90001-2","volume":"8","author":"JF Bach","year":"1995","unstructured":"Bach JF. Insulin-dependent diabetes mellitus as a beta-cell targeted disease of immunoregulation. J Autoimmun. 1995;8:439\u201363.","journal-title":"J Autoimmun"},{"key":"8956_CR34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","volume":"6","author":"S Sakaguchi","year":"2005","unstructured":"Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005;6:345\u201352.","journal-title":"Nat Immunol"},{"key":"8956_CR35","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1210\/en.2004-1520","volume":"146","author":"CT Souza De","year":"2005","unstructured":"De Souza CT, Araujo EP, Bordin S, Ashimine R, Zollner RL, Boschero AC, et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology. 2005;146:4192\u20139.","journal-title":"Endocrinology"},{"key":"8956_CR36","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133:775\u201387.","journal-title":"Cell"},{"key":"8956_CR37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","volume":"22","author":"S Sakaguchi","year":"2004","unstructured":"Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531\u201362.","journal-title":"Annu Rev Immunol"},{"key":"8956_CR38","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1074-7613(00)80195-8","volume":"12","author":"B Salomon","year":"2000","unstructured":"Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, et al. B7\/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 2000;12:431\u201340.","journal-title":"Immunity"},{"key":"8956_CR39","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1084\/jem.20040180","volume":"199","author":"KV Tarbell","year":"2004","unstructured":"Tarbell KV, Yamazaki S, Olson K, Toy P, Steinman RM. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med. 2004;199:1467\u201377.","journal-title":"J Exp Med"},{"key":"8956_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2005.05.003","volume":"235","author":"PA Ott","year":"2005","unstructured":"Ott PA, Anderson MR, Tary-Lehmann M, Lehmann PV. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes. Cell Immunol. 2005;235:1\u201311.","journal-title":"Cell Immunol"},{"key":"8956_CR41","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/9442","volume":"5","author":"MA Atkinson","year":"1999","unstructured":"Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med. 1999;5:601\u20134.","journal-title":"Nat Med"},{"key":"8956_CR42","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.177.6.3695","volume":"177","author":"D Ly","year":"2006","unstructured":"Ly D, Mi QS, Hussain S, Delovitch TL. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells. J Immunol. 2006;177:3695\u2013704.","journal-title":"J Immunol"},{"key":"8956_CR43","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2337\/diabetes.55.04.06.db05-1048","volume":"55","author":"D Chen","year":"2006","unstructured":"Chen D, Zhang N, Fu S, Schroppel B, Guo Q, Garin A, et al. CD4+ CD25+ regulatory T-cells inhibit the islet innate immune response and promote islet engraftment. Diabetes. 2006;55:1011\u201321.","journal-title":"Diabetes"},{"key":"8956_CR44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1084\/jem.20061631","volume":"204","author":"KV Tarbell","year":"2007","unstructured":"Tarbell KV, Petit L, Zuo X, Toy P, Luo X, Mqadmi A, et al. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med. 2007;204:191\u2013201.","journal-title":"J Exp Med"},{"key":"8956_CR45","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.immuni.2008.12.022","volume":"30","author":"N Zhang","year":"2009","unstructured":"Zhang N, Schroppel B, Lal G, Jakubzick C, Mao X, Chen D, et al. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity. 2009;30:458\u201369.","journal-title":"Immunity"},{"key":"8956_CR46","doi-asserted-by":"crossref","first-page":"179ra142","DOI":"10.1126\/scitranslmed.3005681","volume":"5","author":"MP Kurnellas","year":"2013","unstructured":"Kurnellas MP, Adams CM, Sobel RA, Steinman L, Rothbard JB. Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation. Sci Transl Med. 2013;5:179ra142.","journal-title":"Sci Transl Med"},{"key":"8956_CR47","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1084\/jem.20080308","volume":"205","author":"J Andersson","year":"2008","unstructured":"Andersson J, Tran DQ, Pesu M, Davidson TS, Ramsey H, O'Shea JJ, et al. CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner. J Exp Med. 2008;205:1975\u201381.","journal-title":"J Exp Med"},{"key":"8956_CR48","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1073\/pnas.0400810101","volume":"101","author":"Y Peng","year":"2004","unstructured":"Peng Y, Laouar Y, Li MO, Green EA, Flavell RA. TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc Natl Acad Sci U S A. 2004;101:4572\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8956_CR49","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/eji.200939618","volume":"40","author":"L Lu","year":"2010","unstructured":"Lu L, Ma J, Wang X, Wang J, Zhang F, Yu J, et al. Synergistic effect of TGF-beta superfamily members on the induction of Foxp3+ Treg. Eur J Immunol. 2010;40:142\u201352.","journal-title":"Eur J Immunol"},{"key":"8956_CR50","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1189\/jlb.1003482","volume":"75","author":"A Mazzoni","year":"2004","unstructured":"Mazzoni A, Segal DM. Controlling the Toll road to dendritic cell polarization. J Leukoc Biol. 2004;75:721\u201330.","journal-title":"J Leukoc Biol"},{"key":"8956_CR51","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/90609","volume":"2","author":"S Akira","year":"2001","unstructured":"Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2:675\u201380.","journal-title":"Nat Immunol"},{"key":"8956_CR52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2567.2007.02651.x","volume":"122","author":"G Liu","year":"2007","unstructured":"Liu G, Zhao Y. Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells. Immunology. 2007;122:149\u201356.","journal-title":"Immunology"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-017-8956-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-017-8956-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-017-8956-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T02:08:16Z","timestamp":1518055696000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-017-8956-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,5]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["8956"],"URL":"https:\/\/doi.org\/10.1007\/s12026-017-8956-5","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,5]]}}}